It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
In proliferating multipotent retinal progenitors, transcription factors dynamics set the fate of postmitotic daughter cells, but postmitotic cell fate plasticity driven by extrinsic factors remains controversial. Transcriptome analysis reveals the concurrent expression by postmitotic rod precursors of genes critical for the Müller glia cell fate, which are rarely generated from terminally-dividing progenitors as a pair with rod precursors. By combining gene expression and functional characterisation in single cultured rod precursors, we identified a time-restricted window where increasing cell culture density switches off the expression of genes critical for Müller glial cells. Intriguingly, rod precursors in low cell culture density maintain the expression of genes of rod and glial cell fate and develop a mixed rod/Muller glial cells electrophysiological fingerprint, revealing rods derailment toward a hybrid rod-glial phenotype. The notion of cell culture density as an extrinsic factor critical for preventing rod-fated cells diversion toward a hybrid cell state may explain the occurrence of hybrid rod/MG cells in the adult retina and provide a strategy to improve engraftment yield in regenerative approaches to retinal degenerative disease by stabilising the fate of grafted rod precursors.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Andreazzoli, Massimiliano 3 ; Angeloni, Debora 7 ; Demontis, Gian Carlo 9 1 University of Pisa, Department of Pharmacy, Pisa, Italy (GRID:grid.5395.a) (ISNI:0000 0004 1757 3729); Scuola Superiore Sant’Anna, Pisa, Italy (GRID:grid.263145.7) (ISNI:0000 0004 1762 600X)
2 Scuola Superiore Sant’Anna, Pisa, Italy (GRID:grid.263145.7) (ISNI:0000 0004 1762 600X); University of Pisa, Department of Biology, Pisa, Italy (GRID:grid.5395.a) (ISNI:0000 0004 1757 3729)
3 University of Pisa, Department of Biology, Pisa, Italy (GRID:grid.5395.a) (ISNI:0000 0004 1757 3729)
4 University of Pisa, Department of Biology, Pisa, Italy (GRID:grid.5395.a) (ISNI:0000 0004 1757 3729); Fondazione Pisana per la Scienza, San Giuliano Terme, Italy (GRID:grid.5395.a)
5 Scuola Superiore Sant’Anna, Pisa, Italy (GRID:grid.263145.7) (ISNI:0000 0004 1762 600X); Donald Danforth Plant Science Center, St. Louis, USA (GRID:grid.34424.35) (ISNI:0000 0004 0466 6352)
6 San Raffaele Hospital, Milan, Italy (GRID:grid.18887.3e) (ISNI:0000000417581884)
7 Scuola Superiore Sant’Anna, Pisa, Italy (GRID:grid.263145.7) (ISNI:0000 0004 1762 600X)
8 San Raffaele Hospital, Milan, Italy (GRID:grid.18887.3e) (ISNI:0000000417581884); National Research Council of Italy, Institute of Neuroscience, Milan, Italy (GRID:grid.5326.2) (ISNI:0000 0001 1940 4177)
9 University of Pisa, Department of Pharmacy, Pisa, Italy (GRID:grid.5395.a) (ISNI:0000 0004 1757 3729)




